NCT07371663 2026-01-28An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid TumorsBeijing Tide Pharmaceutical Co., LtdPhase 1/2 Recruiting266 enrolled
NCT04095273 2024-04-02Study to Test How Well Patients With Advanced Solid Tumors Respond to Treatment With the Elimusertib in Combination With Pembrolizumab, to Find the Optimal Dose for Patients, How the Drug is Tolerated and the Way the Body Absorbs, Distributes and Discharges the DrugBayerPhase 1 Completed56 enrolled